Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Immtech and Tufts studying new drug for common water-borne human parasites

May 3, 2000

New motilin receptor antagonists in the Chugai pipeline

May 3, 2000

Pirfenidone: effects on PDGF-induced intracellular events described at EASL meeting

May 2, 2000

Blockade of ETA receptors as promising strategy for antifibrotic therapy

May 2, 2000

Licensing opportunity from NIH: novel treatment for inflammatory bowel disease

May 2, 2000

PEG-Intron at least as effective and safe as Intron A in phase III HCV trial

April 28, 2000

Synergistic anti-HBV combinations under study at Glaxo Wellcome

April 28, 2000

SB researchers design potent and selective 5-HT4 receptor antagonist

April 27, 2000

Newly issued U.S. patent protects Questcor's position in anti-HCV drug discovery

April 27, 2000

Y-27632 demonstrates beneficial effects on hepatic fat-storing cells and hepatic fibrosis

April 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026